(Q35119232)

6 August 2017

1 reference

title

Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease (English)

1 reference

6 August 2017

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Agonists for Neurological Disease (English)

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

29 December 2023

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

29 December 2023

author name string

Douglas L. Feinstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725709

29 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12725709

29 December 2023

publication date

1 January 2003

1 reference

full work available at URL

6 August 2017

http://www.liebertpub.com/doi/pdf/10.1089/152091503763816481

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Diabetes technology & therapeutics

29 December 2023

published in

1 reference

6 August 2017

5

1 reference

6 August 2017

1

1 reference

6 August 2017

67-73

1 reference

Localization of the peroxisome proliferator-activated receptor in the brain

6 August 2017

1

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei

29 December 2023

2

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease

29 December 2023

4

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis

29 December 2023

5

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

29 December 2023

6

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons

29 December 2023

7

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma

29 December 2023

8

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis

29 December 2023

9

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.

29 December 2023

10

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells

29 December 2023

11

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells

29 December 2023

12

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists

29 December 2023

13

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

T cells, cytokines, and autoantigens in multiple sclerosis.

29 December 2023

14

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

29 December 2023

15

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

29 December 2023

16

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

29 December 2023

17

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2

29 December 2023

18

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

29 December 2023

19

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Indomethacin reverses the microglial response to amyloid beta-protein.

29 December 2023

20

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Inhibition of inducible nitric oxide synthase gene expression by indomethacin or ibuprofen in beta-amyloid protein-stimulated J774 cells

29 December 2023

21

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions

29 December 2023

22

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

29 December 2023

23

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma.

29 December 2023

24

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

29 December 2023

25

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha

29 December 2023

26

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.

29 December 2023

27

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo

29 December 2023

28

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Inflammation and Alzheimer's disease

29 December 2023

29

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Clinical trial of indomethacin in Alzheimer's disease.

29 December 2023

30

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Risk of Alzheimer's disease and duration of NSAID use.

29 December 2023

31

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease

29 December 2023

32

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

29 December 2023

33

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

29 December 2023

Multiple sclerosis

34

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Immunologic therapy of multiple sclerosis

29 December 2023

35

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Current immunotherapy in multiple sclerosis

29 December 2023

36

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

What is new in the treatment of multiple sclerosis?

29 December 2023

37

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Interferon beta for multiple sclerosis

29 December 2023

38

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Interferon beta treatment for multiple sclerosis: persisting questions

29 December 2023

39

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secon

29 December 2023

40

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

29 December 2023

42

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

29 December 2023

43

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

29 December 2023

44

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma

29 December 2023

45

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis

29 December 2023

46

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation

29 December 2023

47

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

29 December 2023

49

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation

29 December 2023

51

1 reference

https://api.crossref.org/works/10.1089/152091503763816481

29 December 2023

Identifiers

1 reference

6 August 2017

1 reference